8348
T. Nagata et al. / Tetrahedron Letters 42 (2001) 8345–8349
cyclization of 21 under the above optimal reaction
conditions proceeded smoothly to give 22 in 49% yield
from 20. The acetoxypropyl side chain at the furan ring
was then converted to a 3-butenyl group by conven-
tional transformations. The phenylsulfonyl group on
9. For 10: According to 1H NMR, compound 10 was
1
observed as a 1:1 mixture of amide rotamers. H NMR
(300 MHz, CDCl3): l 1.53 (9H, s), 1.85–2.15 (1H, m),
2.25–2.55 (1H, m), 2.67 (1H, d, J=10.8 Hz), 3.34 (1H,
brd, J=16.8 Hz), 3.58 (2H, brt, J=10.8 Hz), 3.98 (1H, d,
J=10.8 Hz), 4.25 (1H, dd, J=16.8, 3.1 Hz), 4.69 (0.5H,
brs), 4.83 (0.5H, brs), 5.43 (1H, t, J=3.1 Hz), 6.30 (1H,
brs), 7.38 (1H, brs), 7.52–7.62 (3H, m), 7.82 (2H, d,
J=7.0 Hz); 13C NMR (75 MHz, CDCl3): l 28.8, 34.0,
34.8, 44.9, 45.9, 46.5, 48.9, 59.1, 60.3, 61.7, 80.6, 105.3,
109.7, 126.4, 127.8, 129.6, 133.3, 135.1, 136.9, 148.7,
149.0, 154.6, 155.3, 162.5; IR (neat, cm−1) w 1697, 1394,
1360, 1167, 1146, 1101; LRMS (EI) 442 (M+).
the
A
ring was then deprotected by sodium
anthracenide and the resulting secondary amine was
alkylated with hexenyl tosylate to give 23,16 which is a
good substrate for testing the RCM reaction to prepare
the F ring in nakadomarin A. The results of the RCM
reaction of 23 and further transformations for the total
synthesis of nakadomarin A will be reported in due
course.
10. (a) David, M.; Dhimane, H.; Vanucci-Bacque´, C.; Lhom-
met, G. Synlett 1998, 206; (b) Ohta, T.; Shiokawa, S.;
Iwashita, E.; Nozoe, S. Heterocycles 1992, 34, 895.
Acknowledgements
1
11. For 12: H NMR (300 MHz, CDCl3): l 1.45 (9H, brs),
1.40–1.95 (9H, m), 2.2–2.60 (2H, m), 3.02–3.06 (1H, m),
3.41–3.51 (2H, m), 3.64–3.70 (2H, m), 3.95–4.09 (2H, m),
7.52–7.63 (3H, m), 7.62–7.75 (2H, m); IR (neat, cm−1) w
1693, 1402, 1365, 1167, 578; LRMS (EI) 448 (M+);
HRMS (EI) calcd for C23H32N2O5S 448.2032; found
448.2055.
This research was supported by a Grant-in-Aid for
Scientific Research of Priority Areas (A) ‘Exploitation
of Multi-Element Cyclic Molecules’ from the Ministry
of Education, Culture, Sports, Science, and Technol-
ogy. The financial supports by Uehara Memorial Foun-
dation and the Fugaku Trust for Medical Research are
also acknowledged. We also thank Mr. T. Kano for his
technical assistance and Ms. R. Hara at the Analytical
Center, Chiba University, for performing the mass
spectroscopy.
12. For 14: 1H NMR (300 MHz, CDCl3): l 1.50 (9H, s, Boc),
1.57–1.71 (2H, m, Hb-4%, Ha-5), 1.92–2.03 (1H, m, Ha-
4%), 2.45 (1H, dd, J=12.1, 3.9 Hz, Ha-4), 2.51 (1H, ABq,
J=12.4 Hz, Ha-2), 2.55–2.64 (1H, m, Ha-6), 2.70–2.85
(1H, m, Hb-5), 3.17–3.25 (1H, m, Ha-3%), 3.41–3.67 (1H,
m, Hb-3%), 3.74 (1H, dd, J=11.6, 1.5 Hz, Hb-6), 3.96
(1H, ABq, J=12.4, 1.5 Hz, Hb-2), 6.31 (1H, d, J=1.9
Hz, H-4%%), 7.28 (1H, brd, J=1.4 Hz, H-2%%), 7.32 (1H,
brd, J=1.6 Hz, H-5%%), 7.54–7.61 (3H, m, Bs), 7.88 (2H,
dd, J=8.0, 1.7 Hz, Bs); 13C NMR (75 MHz, CDCl3): l
28.2 (C5), 28.5 (tBu), 28.9 (C4%), 40.5 (C4), 42.8 (C3%),
46.3 (C6), 47.9 (C3), 52.1 (C2), 83.2 (tBu), 110.9 (C4%%),
124.2 (C3%%), 128.4 (Bs), 129.4 (Bs), 133.2 (Bs), 137.2 (Bs),
140.7 (C2%%), 143.5 (C5%%), 150.4 (C=O), 173.1 (C1%); IR
(KBr, cm−1) w 1755, 1712, 1323, 1155; HRMS (FAB)
calcd for C23H28N2OSNa 483.1566 (M+Na+); found
483.1596.
References
1. (a) Kobayashi, J.; Watanabe, D.; Kawasaki, N.; Tsuda,
M. J. Org. Chem. 1997, 62, 9236–9239; (b) Kobayashi, J.;
Tsuda, M.; Ishibashi, M. Pure Appl. Chem. 1999, 71,
1123–1126.
2. (a) Uchida, H.; Nishida, A.; Nakagawa, M. Tetrahedron
Lett. 1999, 40 (1), 113–116; (b) Nakagawa, M.; Torisawa,
Y.; Uchida, H.; Nishida, A. J. Synth. Org. Chem., Jpn.
1999, 57, 1004–1015.
3. A part of this study has been reported in 10th Interna-
tional symposium on Marine Natural Products, Oki-
nawa, Japan, June 24–29 2001, abstract p. 45.
13. For 13: 1H NMR (300 MHz, CDCl3): l 1.53 (9H, s, Boc),
1.57–1.64 (1H, m, Hb–5), 1.87–1.92 (2H, m, Ha,b-4%),
2.01–2.08 (1H, m, Ha-5), 2.76 (1H, brt, J=6.3 Hz, Ha-4),
3.06–3.25 (2H, m, Ha,b-6), 3.08 (1H, ABq, J=12.4 Hz,
Ha-2), 3.26–3.75 (2H, m, H-3%), 3.34 (1H, ABq, J=12.4
Hz, Hb-2), 4.65 (1H, s, Hb-1%), 6.14 (1H, d, J=1.8 Hz,
H-4%%), 7.33 (1H, brs, H-5%%), 7.50–7.63 (3H, m. Bs), 7.77
(2H, dd, J=8.4, 1.5 Hz, Bs); 13C NMR (75 MHz,
CDCl3): l 27.6 (C5), 28.8 (tBu), 36.3 (C4%%), 39.1 (C4),
42.8 (C6), 45.3 (C3%), 50.0 (C2), 61.2 (C3), 62.5 (C1%), 80.5
(tBu), 107.3 (C4%%), 127.7 (Bs), 128.9 (C3%%), 129.6 (Bs),
133.1 (Bs), 137.8 (Bs), 147.7 (C5%%), 154.8 (CꢀO), 157.3
(C2%%); IR (neat, cm−1) w 1693, 1398, 1167, 737; HRMS
(FAB) calcd for C23H28N2O5SNa 467.1617 (M+Na+);
found 467.1629.
4. Very recently, Dr. Fu¨rstner, Max-Planck-Institute, Ger-
many, independently reported a synthetic approach to
nakadomarin A. 18th International Congress of Hetero-
cyclic Chemistry, Yokohama, Japan, July 29–August 3
2001, abstract p. 86. Their preliminary report on the
synthesis of nakadomarin A: Fu¨rstner, A.; Guth, O.;
Rumbo, A.; Seidel, G. J. Am. Chem. Soc. 1999, 121,
11108–11113.
5. Fu¨rstner, A. Angew. Chem., Int. Ed. 2000, 39, 3012–3043.
6. (a) The starting material, methyl 4-oxo-3-piperidinecar-
boxylate, 1 is commercially available and can also be
easily prepared in large scale from simple reagents: Baty,
J. D.; Jones, G.; Moore, C. J. Chem. Soc. (C) 1967,
2645–2647; (b) All of the compounds shown in this paper
are racemic. However, an asymmetric allylation of 1 has
been reported: Shilay, V.; Alyev, A.; Grishina, G. Bull.
Soc. Chim. Belg. 1992, 101, 751–752.
14. Satoh, T.; Nanba, K.; Suzuki, S. Chem. Pharm. Bull.
1971, 19, 817–820. Hydrogenation of the unsaturated
ester moiety only gave ethyl 3-(2-furyl)propionate, a
debrominated product. Sodium borohydride reduction in
the presence of CoCl2 or CuCl2 also gave less satisfactory
results.
7. Brands, K. M. J.; DiMichele, L. M. Tetrahedron Lett.
1998, 39, 1677–1680.
8. Miyaura, N.; Suzuki, A. Chem. Rev. 1995, 95, 2457.